Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@law360
law360.com > lifesciences > articles > 2515018 > dc-circ-revives-part-of-fight-over-braille-free-drug-label

DC Circ. Revives Part Of Fight Over Braille-Free Drug Label

6+ day, 7+ hour ago   (60+ words) Law360 Try our Advanced Search for more refined results The Practice of Law Deep News & Analysis Law360 | The Practice of Law Law360 Authority | Deep News & Analysis Law360 Pulse | The Business of Law DC Circ. Revives Part Of Fight Over Braille-Free Drug Label Law360 is on…...

@law360
law360.com > articles > 2499415

Senate Panel To Weigh 5 ITC Commissioner Picks

1+ mon, 2+ week ago   (21+ words) Law360 Try our Advanced Search for more refined results The Practice of Law...

@law360
law360.com > healthcare-authority > articles > 2453866 > alcon-drops-430m-lensar-deal-under-pressure-from-ftc

Alcon Drops $430M Lensar Deal Under Pressure From FTC - Law360 Healthcare Authority

5+ mon, 1+ week ago   (84+ words) Alcon Drops $430M Lensar Deal Under Pressure From FTC Law360 Alcon Drops $430M Lensar Deal Under Pressure From FTC By Matthew Perlman · March 17, 2026, 3:31 PM EDT Recent Articles By Matthew Get instant access to the one-stop news source for business lawyers Email (NOTE: Free…...

Law360
law360.com > amp > articles > 2453866

Alcon Drops $430M Lensar Deal Under Pressure From FTC

5+ mon, 1+ week ago   (25+ words) Law360 Alcon Drops $430M Lensar Deal Under Pressure From FTC To view the full article, register now....